CAS: 1044511-01-4 - Benralizumab
Formula:Unspecified
- Synonyms:
- Fasenra
- Benralizumab
- MEDI 563
- BIW 8405
- Immunoglobulin G1, anti-(human interleukin 5 receptor α-chain) (human-mouse monoclonal MEDI-563 heavy chain), disulfide with human-mouse monoclonal MEDI-563 κ-chain, dimer
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Benralizumab REF: TM-T10497CAS: 1044511-01-4 | > 95% | 500.00 €~3,211.00 € | Fri 27 Dec 24 |
 | Benralizumab REF: 3D-CLA1249CAS: 1044511-01-4 | - - - | To inquire | Tue 07 Jan 25 |
Benralizumab
CAS:1044511-01-4
Benralizumab (MEDI-563) is a monoclonal antibody targeting the interleukin-5 receptor alpha (IL-5Rα).
Purity:
> 95%
Color and Shape:
Liquid
Molecular weight:
146.06 kDa
Ref: TM-T10497
| 1mg | 500.00 € | ||
| 2mg | 806.00 € | ||
| 5mg | 1,383.00 € | ||
| 10mg | 2,153.00 € | ||
| 25mg | 3,211.00 € |
Estimated delivery in United States, on Friday 27 Dec 2024
Ref: 3D-CLA1249
| Undefined size | To inquire |
Estimated delivery in United States, on Tuesday 7 Jan 2025
